From the Editor

TON July 2016 Vol 9 No 4 - From the Editors
Beth Faiman, PhD, APRN-BC, AOCN
Editor in Chief

In the July issue of The Oncology Nurse-APN/PA, we feature the Fairfield Medical Center from Lancaster, OH. They have a comprehensive cancer program where medical oncologists, radiation oncologists, surgeons, oncology nurses, and other team members work together to provide an individualized treatment plan for every patient.

Another featured article this month is the Genetic Counseling column by Cristi Radford, MS, CGC. In her article, she talks about novel ovarian cancer genes as well as risk-reducing salpingo-oophorectomy. For more information about these genes, see “‘Newer’ Ovarian Cancer Genes, Option of Risk-Reducing Salpingo-Oophorectomy.”

Don’t forget to read about the lastest research presented at conferences in our conference news section. This month, we continue to cover news from the 2016 American Society of Clinical Oncology (ASCO) Quality Care Symposium, bringing you the latest from the Oncology Nursing Society 41st Annual Congress, as well as data from the 2016 Community Oncology Conference. 

In addition, we share a technology update on CancerLinQ, the big data cancer database from ASCO. “We have to create a platform that will accept data from different systems to enable interoperability across many sources,” explained Robert S. Miller, MD, a medical oncologist and Vice President, ASCO Quality and Guidelines, and Medical Director of CancerLinQ. We also report on an electronic “facility board,” a communication tool that was created to easily look at patient status and improve communication. The board led to more clinical interventions for abnormal vital signs, a reduction in falls among high-risk patients, and more ordering of specialty beds. 

This issue also includes articles on a variety of treatments and conditions, including immunotherapy, head and neck cancer, sexual health, palliative care, and side effect management. In particular, the article about immunotherapy provides information about separating facts from fiction. “Cancer is inherently robust. We’ve learned this over decades and decades of failure; we’ve seen it become resistant, and patients die. And this has not changed, ultimately, even though some patients do well,” according to the researcher.

In this issue’s reader poll, we ask about your confidence level explaining genomic information to patients. Please visit our website, TheOncologyNurse.com, and let us know whether this is something you are comfortable doing. We hope you enjoy this issue, and as always, we look forward to your feedback. 

Related Items
From The Editors - TOP November 2017
TOP - November 2017, Vol 10, No 4 published on November 13, 2017 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - September 2017, Vol 10, No 5 published on September 10, 2017 in Cancer Center Profile
From the Editors
Patrick J. Medina, PharmD, BCOP, Steven Stricker, PharmD, MS, BCOP
TOP - August 2017, Vol 10, No 3 published on August 1, 2017 in From the Editors
From the Editor
Beth Faiman, PhD, APRN-BC, AOCN
TON - July 2017, Vol 10, No 4 published on July 6, 2017 in From the Editors
From the Editor
TON - May 2017, Vol 10, No 3 published on May 17, 2017 in From the Editors
From the Editors
Patrick J. Medina, PharmD, BCOP, Steve Stricker, PharmD, MS, BCOP
TOP - May 2017, Vol 10, No 2 published on May 5, 2017 in From the Editors
Staying Abreast of New Treatments
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent published on April 18, 2017 in ASH 2016 - Multiple Myeloma, Hematologic Cancers, Conference Correspondent
Managing Patients with Multiple Myeloma
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent published on April 18, 2017 in ASH 2016 - Multiple Myeloma, Hematologic Cancers, Conference Correspondent
Perceptions of Daratumumab Therapy
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent published on April 18, 2017 in ASH 2016 - Multiple Myeloma, Hematologic Cancers, Conference Correspondent
Starting a Patient on Daratumumab
Beth Faiman, PhD, APRN-BC, AOCN
Conference Correspondent published on April 18, 2017 in ASH 2016 - Multiple Myeloma, Hematologic Cancers, Conference Correspondent
Last modified: July 26, 2016